Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f8fe90bd741939b669967410a817918 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-01092 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-01038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-01092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 |
filingDate |
2015-08-04^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cf036e3fec8e73880f0f905956be0c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ed9ac967d4802e4ade2ed9ae467c70e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c91ed2febc80730af6d1ec826afb56a2 |
publicationDate |
2017-03-17^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20170030648-A |
titleOfInvention |
Process for the modification of a glycoprotein using a beta-(1,4)-n-acetylgalactosaminyltransferase or a mutant thereof |
abstract |
The present invention relates to a method for transforming a glycoprotein using? - (1,4) -N-acetylgalactosamininyltransferase or a mutant thereof. The method comprises contacting a glycoprotein comprising a glycan comprising a terminal GlcNAc moiety with a non-natural sugar derivative nucleotide in the presence of? - (1,4) -N-acetylgalactosamininyltransferase or a mutant thereof, . The non-natural sugar derivative nucleotide is according to the formula (3). Wherein, A is -N 3; -C (O) R < 3 & gt ;; -C = CR 4; -SH; -SC (O) R < 8 & gt ;; -SC (V) OR 8 , wherein V is O or S; -X, wherein X is selected from the group consisting of F, Cl, Br and I; -OS (O) 2 R < 5 & gt ;; An optionally substituted C 2 -C 24 alkyl group; Optionally substituted terminal C 2 -C 24 alkenyl group; And it is optionally selected from the terminal C 3 -C 24 alkenyl group substituted by the group consisting of Al. |
priorityDate |
2014-08-04^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |